Related Experiment Video
Updated: Feb 25, 2026
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.7K
Association between platelet function and recurrent ischemic vascular events after TIA and minor stroke
Summary
Platelet function, particularly aggregation levels, is linked to recurrent ischemic events in minor stroke and TIA patients. CYP2C19 loss-of-function alleles impact clopidogrel response, influencing these vascular events.
Area of Science:
- Neurology
- Cardiology
- Pharmacogenomics
Background:
- Platelet activation and aggregation are crucial in ischemic vascular events.
- Understanding platelet function post-stroke is vital for preventing recurrence.
Purpose of the Study:
- To investigate the association between platelet function and recurrent ischemic vascular events in patients with TIA or minor stroke.
- To identify risk factors for these recurrent events.
Main Methods:
- A cohort of 417 patients receiving clopidogrel-aspirin therapy were studied.
- Platelet aggregation ratios (MAR-AA, MAR-ADP) and CYP2C19 genotypes were assessed.
- Patients were followed for 6 months for recurrent ischemic events.
Main Results:
- Higher MAR-AA (aspirin) and MAR-ADP (clopidogrel) were significantly associated with recurrent ischemic events.
- CYP2C19 loss-of-function (LOF) allele carriage was a risk factor for recurrent events.
- CYP2C19 LOF carriers showed altered clopidogrel response at 75mg but not 300mg.
Conclusions:
- Platelet function, specifically aggregation ratios, is a significant predictor of recurrent ischemic vascular events.
- CYP2C19 genotype influences clopidogrel efficacy, highlighting its role in personalized stroke prevention.
- These findings underscore the importance of monitoring platelet function and considering pharmacogenomics in managing patients at risk for recurrent stroke.
Related Concept Videos
01:22Formation of the Platelet Plug
10.0K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.0K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
01:16Clot Retraction and Fibrinolysis
9.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.5K
01:18Structure and Function of Platelets
4.0K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.0K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
01:30Peripheral Artery Disease I: Introduction
451
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
451